Dow Jones futures were little changed overnight, along with S&P 500 futures and Nasdaq futures. NvidiaNVDA chipmaker Taiwan ...
Investor's Business Daily on MSN

TD SYNNEX sees relative strength rating rise to 73

TD SYNNEX SNX saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 64 to 73.
A Dutch court held hearings Wednesday to weigh whether to order an investigation into Nexperia, a Chinese-owned chip company at the centre of a global tug-of-war over critical semiconductor technology ...
Caldera Therapeutics, Inc. (Caldera), a clinical stage biotechnology company developing the first-in-class bispecific ...
Researchers in Edinburgh have developed a rapid stool-based test aiming to improve the diagnosis of inflammatory bowel ...
Elon Musk's company xAI has faced global backlash in recent days over sexualised "deepfake" images of women and children ...
Corporate profit margins are holding firm, and gains in household wealth are sustaining consumer spending despite labor ...
SKYWAY (NCT07148414) is a Phase 2 basket trial of SPY072 (anti-TL1A) in patients with moderate to severely active RA, PsA, or axSpA. Enrollment is on track, and all indications are expected to readout ...
The term “metagenome” refers to the collective genetic material of microbial organisms within a given environment, which can be observed within or among individual “microbes” (single individuals or ...
In addition, $14B Mather Group acquires, Prime Capital recruits an established RPA, and EY analysts look ahead to the year in ...
Takeda has announced a global collaboration and licence agreement with Halozyme to continue advancing vedolizumab with the ...